InvestorsHub Logo
Followers 0
Posts 41
Boards Moderated 0
Alias Born 03/08/2006

Re: None

Friday, 03/10/2006 7:22:32 PM

Friday, March 10, 2006 7:22:32 PM

Post# of 203990
XKEM----- partner read About Alembic

Alembic is a 97 year old pharmaceutical firm based in Baroda, India. It has obtained ISO-9002, ISO-14001 and WHO-GMP Certifications. Its R&D facilities spearhead landmark research in the areas of chemistry, neurology and pharmaceutical technology and distributes its product to over 75 countries throughout the world.

About Xechem

Xechem International, Inc. is a fully integrated biopharmaceutical company focusing on phytopharmaceuticals and other proprietary technologies for orphan diseases. Its mission is to increase the quality and quantity of life of the people who suffer from these diseases.

This news release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks, uncertainties, including the ability of the Company to obtain necessary regulatory approval for the launch of NICOSAN(TM)/HEMOXIN(TM) in Nigeria and elsewhere, the ability of the Company to fund the cost of development and operation of a manufacturing financing and distribution network for NICOSAN(TM)/HEMOXIN(TM) in Nigeria, the ability to meet its financial obligations to Alembic and others in connection with such project and the ability to raise additional capital, domestically or in Nigeria to fund such project and its other operations, and the amount of dilution to be experienced in Nigeria. Other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements of the Company expressed or implied by such forward-looking statements.
--------------------------------------------------------------------------------
Contact:
Xechem International, Inc.
Ramesh C. Pandey, Ph.D.
732-247-3300; 732-247-4090 fax
xechem@erols.com
or
Wolfe Axelrod Weinberger Assoc. LLC
Donald C. Weinberger
Andria Arena (Media)
212-370-4500; 212-370-4505 fax
don@wolfeaxelrod.com
andria@wolfeaxelrod.com
--------------------------------------------------------------------------------
Source: Xechem International, Inc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.